This brand name is authorized in France
The drug CANTABILINE contains one active pharmaceutical ingredient (API):
|
1
Hymecromone
UNII 3T5NG4Q468 - HYMECROMONE
|
|
Hymecromone is an inhibitor of hyaluronic acid synthesis and has a spasmolytic effect on extrahepatic bile ducts. Hymecromone is an approved prescription drug used for treating biliary spasm. This action takes place through a musculotropic mechanism, without atropinic effects. Increased choleresis is also observed without excitation of gall bladder contraction. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A05AX02 | Hymecromone | A Alimentary tract and metabolism → A05 Bile and liver therapy → A05A Bile therapy → A05AX Other drugs for bile therapy |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 61974317 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
